Lite Strategy, Inc.
LITS
$2.47
-$0.07-2.76%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/10/2025
-
MarketBeat
10/8/2025
-
SeekingAlpha.com: All News
10/8/2025
-
TipRanks Financial Blog
10/8/2025
-
The Fly
10/4/2025
-
MarketBeat
9/21/2025
-
MarketBeat
9/16/2025
-
SeekingAlpha
9/16/2025
-
Seeking Alpha - Long Ideas
9/15/2025
-
TipRanks Financial Blog
9/10/2025
-
Business Wire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
Filings
Filing Date
Friday, September 26, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 369 7100
Address
9920 Pacific Heights Blvd.
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI...
more